6 Holy Cross Cancer Center in Kielce, Kielce, 25-734, Poland Correspondence: Robert Bucki Department of Medical Microbiology and Nanobiomedical Engineering, Medical University of Bialystok, Mickiewicza 2C, Bialystok, 15-222, Poland Tel + 48 85 748 5793 Email [email protected] Background: Even with considerable improvement in treatment of epithelial ovarian cancer achieved in recent years, an increasing chemotherapy resistance and disease 5-year relapse is recorded for a majority part of patients that encourages the search for better therapeutic options
Presented for research literature review only Sills ES et al
Aspectos Clave de Bienestar Ingredientes L-Carnitina es un aminocido vital que impulsa la produccin de energa a travs del transporte de cidos grasos a las mitocondrias celulares
Comorbidities, e.g., type 2 diabetes, dyslipidemia, and gout may exacerbate the disease and thus should be evaluated in NASH patients
Development programs should treat metabolic state and vagal integrity as testable variables, not background noise, and incorporate them into early pharmacodynamic modeling